Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: Findings in 145 unrelated families

European Journal of Endocrinology

Volumn 164, Issue 6, 2011, Pages 977-984

  Nandagopal, Radha ^a,b   Sinaii, Ninet ^c   Avila, Nilo A ^d,e   Van Ryzin, Carol ^b   Chen, Wuyan ^f   Finkielstain, Gabriela P ^a   Mehta, Sneha P ^c   McDonnell, Nazli B ^f   Merke, Deborah P ^a,c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; HYDROXYPROGESTERONE; TETRACOSACTIDE;

ADRENAL HYPERPLASIA; ADULT; AGED; ALOPECIA; ARTICLE; ASYMPTOMATIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTIC NONCLASSIC CONGENITAL ADRENAL HYPERPLASIA; CYP21A2 GENE; ETHNICITY; FAMILY; FEMALE; GENE; GENE MUTATION; GENOTYPE; HIRSUTISM; HUMAN; INCIDENCE; INFERTILITY; MALE; MENSTRUAL IRREGULARITY; MYELOLIPOMA; PARENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; ADRENAL TUMOR; BIOCHEMISTRY; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL ADRENAL HYPERPLASIA; FAMILY HISTORY; FEMALE INFERTILITY; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HORMONE ACTION; HORMONE DETERMINATION; HYPERANDROGENISM; MALE TYPE ALOPECIA; MUTATOR GENE;

ADRENAL GLANDS; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGED; ANTHROPOMETRY; BAYES THEOREM; BODY HEIGHT; COSYNTROPIN; DNA; FEMALE; HORMONES; HUMANS; HYPERANDROGENISM; INFERTILITY; MALE; MIDDLE AGED; PARENTS; PHENOTYPE; PUBERTY; STEROID 21-HYDROXYLASE; TESTIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79957680673     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0019     Document Type: Article

References (39)

1. Merke DP & Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005 365 2125-2136. (doi:10.1016/S0140-6736(05)66736-0)
2. Moran C. Nonclassic adrenal hyperplasia. Fertility and Sterility 2006 86 (Supplement 1) S3. (doi:10.1016/j.fertnstert.2006.03.004)
3. Krone N, Braun A, Roscher AA, Knorr D & Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany Journal of Clinical Endocrinology and Metabolism 2000 85 1059-1065. (doi:10.1210/jc.85.3.1059)
4. Jaaskelainen J, Levo A, Voutilainen R & Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. Journal of Clinical Endocrinology and Metabolism 1997 82 3293-3297. (doi:10.1210/jc.82.10.3293)
5. Therrell BL Jr, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J & Gunn S. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998 101 583-590. (doi:10.1542/peds.101.4.583)
6. Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L & Boots LR. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertility and Sterility 1999 72 915-925. (doi:10.1016/S0015-0282(99)00383-0)
7. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A & New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. American Journal of Human Genetics 1985 37 650-667. (Pubitemid 16249426)
8. Kuttenn F, Couillin P, Girard F, Billaud L, Vincens M, Boucekkine C, Thalabard JC, Maudelonde T, Spritzer P, Mowszowicz I, Boue A & Mauvais-Jarvis P. Late-onset adrenal hyperplasia in hirsutism. New England Journal of Medicine 1985 313 224-231. (doi:10.1056/NEJM198507253130404)
9. Dewailly D, Vantyghem-Haudiquet MC, Sainsard C, Buvat J, Cappoen JP, Ardaens K, Racadot A, Lefebvre J & Fossati P. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 1986 63 418-423. (doi:10.1210/jcem-63-2-418)
10. Bidet M, Bellanne-Chantelot C, Galand-Portier MB, Tardy V, Billaud L, Laborde K, Coussieu C, Morel Y, Vaury C, Golmard JL, Claustre A, Mornet E, Chakhtoura Z, Mowszowicz I, Bachelot A, Touraine P & Kuttenn F. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. Journal of Clinical Endocrinology and Metabolism 2009 94 1570-1578. (doi:10.1210/jc.2008-1582)
11. Finkielstain GP, Chen W, Mehta SP, Fujimura FK, Hanna RM, Van Ryzin C, McDonnell NB & Merke DP. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 2010 96 E161-E172. (doi:10.1210/jc.2010-0319)
12. Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, Knochenhauer ES, Marcondes JA, Mendonca BB, Pignatelli D, Pugeat M, Rohmer V, Speiser PW & Witchel SF. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. American Journal of Obstetrics and Gynecology 2000 183 1468-1474. (doi:10.1067/mob.2000.108020)
13. Moran C, Azziz R, Weintrob N, Witchel SF, Rohmer V, Dewailly D, Marcondes JA, Pugeat M, Speiser PW, Pignatelli D, Mendonca BB, Bachega TA, Escobar-Morreale HF, Carmina E, Fruzzetti F & Kelestimur F. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2006 91 3451-3456. (doi:10.1210/jc.2006-0062)
14. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K & Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. Journal of Clinical Endocrinology and Metabolism 2004 89 453-462. (doi:10.1210/jc.2003-031122)
15. Charmandari E, Merke DP, Negro PJ, Keil MF, Martinez PE, Haim A, Gold PW & Chrousos GP. Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress. Journal of Clinical Endocrinology and Metabolism 2004 89 2228-2236. (doi:10.1210/jc.2003-031322)
16. Knochenhauer ES, Cortet-Rudelli C, Cunnigham RD, Conway-Myers BA, Dewailly D & Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 1997 82 479-485. (doi:10.1210/jc.82.2.479)
17. New MI, Dupont B, Pollack MS & Levine LS. The biochemical basis for genotyping 21-hydroxylase deficiency. Human Genetics 1981 58 123-127. (doi:10.1007/BF00284159)
18. Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield SE, Kohn B, Lerner A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F & New MI. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 1981 53 1193-1198. (doi:10.1210/jcem-53-6-1193)
19. Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield S, Kohn B, Lerner A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F & New MI. Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1980 51 1316-1324. (doi:10.1210/jcem-51-6-1316)
20. Lee PA, Rosenwaks Z, Urban MD, Migeon CJ & Bias WD. Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 1982 55 866-871. (doi:10.1210/jcem-55-5- 866)
21. Erturk E, Jaffe CA & Barkan AL. Evaluation of the integrity of the hypothalamic - pituitary - adrenal axis by insulin hypoglycemia test. Journal of Clinical Endocrinology and Metabolism 1998 83 2350-2354. (doi:10.1210/jc.83.7. 2350)
22. Schmidt IL, Lahner H, Mann K & Petersenn S. Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic - pituitary - adrenal disease. Journal of Clinical Endocrinology and Metabolism 2003 88 4193-4198. (doi:10.1210/jc.2002-021897)
23. Wilson RC, Mercado AB, Cheng KC & New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. Journal of Clinical Endocrinology and Metabolism 1995 80 2322-2329. (doi:10.1210/jc.80.8.2322)
24. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672. (doi:10.1210/jc.84.10.3666)
25. Barbaro M, Lajic S, Baldazzi L, Balsamo A, Pirazzoli P, Cicognani A, Wedell A & Cacciari E. Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2004 89 2402-2407. (doi:10.1210/jc.2003-031630)
26. Zerah M, Ueshiba H,Wood E, Speiser PW, Crawford C, McDonald T, Pareira J, Gruen D & New MI. Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study. Journal of Clinical Endocrinology and Metabolism 1990 70 1662-1667. (doi:10.1210/jcem-70-6-1662)
27. New MI. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 2006 91 4205-4214. (doi:10.1210/jc.2006-1645)
28. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M & White PC. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2010 95 4133-4160. (doi:10.1210/jc.2009-2631)
29. White PC. Neonatal screening for congenital adrenal hyperplasia. Nature Reviews. Endocrinology 2009 5 490-498. (doi:10.1038/nrendo.2009.148)
30. Verma S, Green-Golan L, Vanryzin C, Drinkard B, Mehta SP, Weise M, Eisenhofer G & Merke DP. Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia. Hormone and Metabolic Research 2010 42 607-612. (doi:10.1055/s-0030-1253385)
31. Jaresch S, Kornely E, Kley HK & Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1992 74 685-689. (doi:10.1210/jc.74.3.685)
32. Baumgartner-Parzer SM, Pauschenwein S, Waldhausl W, Polzler K, Nowotny P & Vierhapper H. Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas. Clinical Endocrinology 2002 56 811-816. (doi:10.1046/j.1365-2265.2002.01299.x)
33. Murakami C, Ishibashi M, Kondo M, Ohshiro S, Fujita M, Sato S, Kako M, Furue H, Mizuguchi K & Yamaji T. Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiency. Internal Medicine 1992 31 803-806. (doi:10.2169/internalmedicine.31.803)
34. Nermoen I, Folling I, Vegge K, Larmo A, Nedrebo BG, Husebye ES & Lovas K. Two adults with adrenal myelolipoma and 21-hydroxylase deficiency. Case Reports in Medicine 2009 2009 Article ID 916891. (doi:10.1155/2009/916891)
35. Kenney PJ, Wagner BJ, Rao P & Heffess CS. Myelolipoma: CT and pathologic features. Radiology 1998 208 87-95. (Pubitemid 28323314)
36. Ravichandran R, Lafferty F, McGinniss MJ & Taylor HC. Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 1996 81 1776-1779. (doi:10.1210/jc.81. 5.1776)
37. Oliva A, Duarte B, Hammadeh R, Ghosh L & Baker RJ. Myelolipoma and endocrine dysfunction. Surgery 1988 103 711-715.
38. Armengaud JB, Charkaluk ML, Trivin C, Tardy V, Breart G, Brauner R & Chalumeau M. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. Journal of Clinical Endocrinology and Metabolism 2009 94 2835-2840. (doi:10.1210/jc.2009-0314)
39. Bidet M, Bellanne-Chantelot C, Galand-Portier MB, Golmard JL, Tardy V, Morel Y, Clauin S, Coussieu C, Boudou P, Mowzowicz I, Bachelot A, Touraine P & Kuttenn F. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 2010 95 1182-1190. (doi:10.1210/jc.2009-1383)